Advertisement
Screener

CYPHERPUNK TECHNOLOGIES INC. (CYPH) Deferred Tax Assets, Operating Loss Carryforwards, Domestic

1.6 / 5 stars · 20/63 Roast Me

CYPHERPUNK TECHNOLOGIES INC. Deferred Tax Assets, Operating Loss Carryforwards, Domestic

CYPHERPUNK TECHNOLOGIES INC. (CYPH) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $17.87 million as of 2025-12-31, per its 10-K filed 2026-03-16.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-03-16

  • 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $17.87M.
  • 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $8.87M.
  • 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $3.67M.
  • 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $44.20M.
Period endDeferred Tax Assets, Operating Loss Carryforwards, Domestic
2025-12-31$17.87M
10-K · filed 2026-03-16
2024-12-31$8.87M
10-K · filed 2026-03-16
2023-12-31$3.67M
10-K · filed 2025-03-26
2022-12-31$44.20M
10-K · filed 2024-03-18
2021-12-31$41.21M
10-K · filed 2023-03-24
2020-12-31$33.71M
10-K · filed 2022-03-11
2019-12-31$47.84M
10-K · filed 2021-03-12
2018-12-31$38.53M
10-K · filed 2020-03-16
2017-12-31$33.23M
10-K · filed 2019-04-01
2016-12-31$18.26M
10-K · filed 2018-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06